Product Information
IRBESARTAN 150 MG TABLET is a generic product labeled by Camber Pharmaceuticals Inc., priced at $0.1111 per EA under NDC 31722073005. Its NADAC has been published 48 times since Jul 30, 2025.
Strength
150 mg/1
Manufacturer
Camber Pharmaceuticals Inc.NDC
31722073005
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
IRBESARTANApproval Type
Generic (ANDA)
FDA Application
ANDA202910On Market Since
9/27/2012
Pharmacological Classes
Price Statistics
The NADAC for IRBESARTAN 150 MG TABLET has been published 48 times since Jul 30, 2025, and over the history we have for it it has declined 8.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1111 per EA |
|---|---|
| All-time high | $0.1211 (Aug 13, 2025) |
| All-time low | $0.1103 (Apr 22, 2026) |
| 52-week high | $0.1211 |
| 52-week low | $0.1103 |
| Median price | $0.1148 |
| Average price | $0.1143 |
| Largest weekly change | -2.6% (Feb 18, 2026) |
| Weeks tracked | 48 |
| Tracking since | Jul 30, 2025 |
Generic Alternatives
The matcher finds 6 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 6 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of IRBESARTAN 150 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for IRBESARTAN 150 MG TABLET, manufactured by Camber Pharmaceuticals Inc., is $0.1111 per EA (NDC 31722073005), effective Jun 24, 2026.
How has the price of IRBESARTAN 150 MG TABLET changed over time?
Over the history we have for it, the NADAC for IRBESARTAN 150 MG TABLET has declined 8.2%. It has been tracked across 48 weekly CMS publications since Jul 30, 2025.
What are the highest and lowest recorded NADAC prices for IRBESARTAN 150 MG TABLET?
Since Jul 30, 2025, the NADAC for IRBESARTAN 150 MG TABLET has ranged from a low of $0.1103 (Apr 22, 2026) to a high of $0.1211 (Aug 13, 2025), with a median of $0.1148 per EA.
Are there cheaper alternatives to IRBESARTAN 150 MG TABLET?
6 NADAC-published products share the same active ingredient, strength, and dosage form as IRBESARTAN 150 MG TABLET, but none are currently priced below it.
Who manufactures IRBESARTAN 150 MG TABLET?
IRBESARTAN 150 MG TABLET (NDC 31722073005) is labeled by Camber Pharmaceuticals Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification